BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8803464)

  • 1. [Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
    Czerwionka-Szaflarska M; Sobkowiak E
    Pediatr Pol; 1996 Jul; 71(7):605-7. PubMed ID: 8803464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection.
    Rapp RP; Billeter M; Hatton J; Young AB; Tibbs PA; Dempsey RJ
    Clin Pharm; 1991 Jan; 10(1):49-55. PubMed ID: 1999086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
    Roberts JA; Webb SA; Lipman J
    Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
    Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
    Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
    Beuscart C; Leroy O; Mouton Y; Pappo M; Drugeon H
    Pathol Biol (Paris); 1989 May; 37(5):496-9. PubMed ID: 2674875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance patterns in children hospitalized for urinary tract infections.
    Lutter SA; Currie ML; Mitz LB; Greenbaum LA
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):924-8. PubMed ID: 16203936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
    Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of nosocomial pneumonia: monotherapy versus combination therapy.
    Greco T
    Geriatrics; 1989 Aug; 44 Suppl A():28-31. PubMed ID: 2777095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical results of the treatment of bacterial infections in children with ceftazidime].
    Zoch-Zwierz W; Rudobielska M; Wierciński R; Winiecka W; Tomaszewska B
    Pol Tyg Lek; 1989 Apr; 44(17):390-3. PubMed ID: 2696939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime in patients with severe Pseudomonas infections.
    Lechi A; Arosio E; Montesi G; Vaona B; Ghidini O; Parrinello E
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):159-64. PubMed ID: 3516892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Escherichia coli isolates from inpatients with urinary tract infections in hospitals in Addis Ababa and Stockholm.
    Ringertz S; Bellete B; Karlsson I; Ohman G; Gedebou M; Kronvall G
    Bull World Health Organ; 1990; 68(1):61-8. PubMed ID: 2189587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems of antibiotic therapy].
    Fortschr Med; 1978 Dec; 96(46):2336-7. PubMed ID: 363577
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum beta-lactamases and clinical outcomes: current data.
    Ramphal R; Ambrose PG
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S164-72. PubMed ID: 16544267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cefepime versus ceftazidime in the treatment of adult pneumonia.
    Lin JC; Yeh KM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2001 Jun; 34(2):131-7. PubMed ID: 11456359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aztreonam in urinary tract infections.
    Roberts JA
    Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.